Ortho Clinical Diagnostics (OCD), once part of Johnson & Johnson and recently acquired by The Carlyle Group, is a force in the world of transfusion medicine and laboratories. Its singular goal “is to help hospitals, laboratories and blood centers worldwide deliver results that help patients experience a better quality of life.”
Yet, there were pitfalls holding OCD back. Members of its global sales team had little in the way of structure and guidance to unify their sales efforts into one cohesive plan of attack.